Survival outcomes in patients with previously untreated BRAF wild-type advanced melanoma treated with Nivolumab therapy: three-year follow-up of a randomized phase 3 trial - Ascierto, Paolo; Hassel, Jessica C.; Schadendorf, Dirk (JAMA oncology, 2019)
Gesehen am 20.09.2019